Visions Clinical Research is categorized under Medical Labs in Boynton Beach, FL and active since 2001.
Visions Clinical Research was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6219993 by the NAICS.
If you are seeking more information, feel free to contact Keith Aqua, Executive Director at the company’s single location by writing to 8188 South Jog Road # 204, Boynton Beach, Florida FL 33472 or by phoning (561) 964-7880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Visions Clinical Research |
| Contact Person: | Keith Aqua, Executive Director |
| Address: | 8188 South Jog Road # 204, Boynton Beach, Florida 33472 |
| Phone Number: | (561) 964-7880 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 6219993 |
| Share This Business: |
Visions Clinical Research was started in 2001 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Keith Aqua, Executive Director for inquiries that concern Visions Clinical Research by calling the company number (561) 964-7880, as your correspondence is most welcome. Additionally, the physical location of the single location of Visions Clinical Research can be found at the coordinates 26.5552,-80.14954 as well as the street address 8188 South Jog Road # 204 in Boynton Beach, Florida 33472.
For its online presence, you may visit Visions Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.